郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's disease.

期刊：Journal of medicinal chemistry发表年份：2012作者：Michael A Brodney; David E Johnson; Aarti Sawant-Basak; Karen J Coffman; Elena M Drummond; Emily L Hudson; Katherine E Fisher; Hirohide Noguchi; Nobuaki Waizumi; Laura L McDowell; Alexandros Papanikolaou; Betty A Pettersen; Anne W Schmidt; Elaine Tse
阅读更多 →

药效评价2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.

期刊：Journal of medicinal chemistry发表年份：2012作者：Myeong Seop Kim; HyungChul Ryu; Dong Wook Kang; Seong-Hee Cho; Sejin Seo; Young Soo Park; Mi-Yeon Kim; Eun Joo Kwak; Yong Soo Kim; Rahul S Bhondwe; Ho Shin Kim; Seul-gi Park; Karam Son; Sun Choi; Ian A DeAndrea-Lazarus; Larry V Pearce; Peter M Blumbe
阅读更多 →

药效评价Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism.

期刊：British journal of pharmacology发表年份：2012作者：Nicolette C Ross; Kate J Reilley; Thomas F Murray; Jane V Aldrich; Jay P McLaughlin
阅读更多 →

药效评价Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.

期刊：Neuroscience发表年份：2012作者：P W Brownjohn; J C Ashton
阅读更多 →